NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球抗核抗體 (ANA) 檢測市場(2021-2027)

Antinuclear Antibody (ANA) Test Market 2021-2027

出版商 Orion Market Research Pvt Ltd 商品編碼 1025335
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球抗核抗體 (ANA) 檢測市場(2021-2027) Antinuclear Antibody (ANA) Test Market 2021-2027
出版日期: 2021年06月23日內容資訊: 英文
簡介

全球抗核抗體 (ANA) 檢測市場:按產品類型(檢測試劑盒/試劑、抗核抗體檢測系統、抗核抗體檢測軟件)、按檢測類型(間接免疫螢光、□結合免疫螢光)(ELISA)、多重方法),按疾病類型(系統性紅斑、乾燥症候群、類風濕性關節炎、硬皮病等),按終端用戶(醫院、實驗室),按地區,市場規模預測,份額和趨勢分析報告(2021-2027)

預計全球 ANA 檢查市場在預測期內將以 12.3% 的複合年增長率顯著增長。在幾個重要趨勢的背景下,預計市場將在預測期內出現顯著增長,包括自身免疫性疾病的高患病率和對自身免疫性疾病的認識提高。根據美國自身免疫病協會(AARDA)的數據,自身免疫病影響了美國約 5000 萬人,而且這個數字還在逐年增加。自身免疫性疾病是 65 歲以下女性的十大死因之一。據 AARDA 稱,女性佔自身免疫性疾病患者的 75%。 ANA 測試被專科醫生和初級保健機構用於診斷和治療自身免疫性疾病,例如係統性紅斑狼瘡 (SLE) 和類風濕性關節炎。自從 ANA 從 SLE 測試中重新用於測試所有自身免疫性疾病以來,這些測試的使用有所增加。

全球 ANA 檢測市場在 COVID-19 危機期間表現出強勁增長,從 2020 年第一季度到第二季度,對大量患者進行篩查和檢測的需求不斷增長。由於在醫院進行大量診斷測試,醫院和臨床實驗室是主要收入來源的最終用戶,需求旺盛,而 COVID-19 的影響增加了對 ANA 測試的需求,以及MRO. 主要參與者正在關注各種因素,包括客戶對全日空預訂的履行。

全球 ANA 市場根據產品類型、測試類型、疾病類型和最終用戶進行分類。按產品類型分為檢測試劑盒/試劑、抗核抗體檢測系統、抗核抗體檢測軟件。按試驗類型分為間接免疫螢光法、□聯免疫吸附試驗(ELISA)和多重法。根據疾病類型,它分為系統性紅斑狼瘡、乾燥綜合徵、類風濕性關節炎、硬皮病等(Azison 病、肺纖維化)。根據最終用戶,市場分為醫院和臨床實驗室。

本報告調查了全球抗核抗體 (ANA) 檢測市場、市場概況、市場增長和抑制因素分析、市場機會、產品類型/檢測類型/疾病類型/最終用戶/地區。它提供了系統信息,例如作為不同的市場規模趨勢和預測、競爭條件和主要公司的概況。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢

第 3 章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
  • 重要的戰略分析
  • COVID-19 對主要參與者的影響

第 4 章市場決定因素

  • 增長因素
  • 抑制因素
  • 市場機會

第 5 章市場細分

  • 按產品類型
    • 檢測試劑盒和試劑
    • 抗核抗體檢測系統
    • 抗核抗體檢測軟件
  • 按檢驗類型
    • 間接免疫螢光
    • □免疫分析法 (ELISA)
    • 多重檢驗
  • 按疾病類型
    • 系統性紅斑狼瘡
    • 乾燥綜合徵
    • 類風濕性關節炎
    • 硬皮病
    • 其他(艾迪森氏病和肺纖維化、間質性肌炎、)
  • 最終用戶
    • 醫院
    • 臨床實驗室

第 6 章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他領域

第 7 章公司簡介

  • Abbott Laboratories
  • Abcam Plc.
  • AESKU.GROUP GmbH
  • American Laboratory Products Company(ALPCO)
  • AMS S.r.l
  • Antibodies Inc.
  • Aviva Systems Biology Corp.
  • BIOCOM Africa(Biotech)
  • Bio-Rad Laboratories, Inc.
  • ELITechGroup
  • Erba Diagnostics Mannheim GmbH
  • EUROIMMUN MedizinischeLabordiagnostika AG
  • Hycor Biomedical Inc.
  • Immuno Concepts NA Ltd.
  • Inova Diagnostics, Inc.
  • MBL International Corp.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • TrueHealthLabs.com.
  • Wiener Laboratorios SAIC
  • ZEUS Scientific, Inc.
目錄
Product Code: OMR2023749

Global Antinuclear Antibody (ANA) Test Market Size, Share & Trends Analysis Report by Product Type (Assay Kits & Reagents, Antinuclear Antibody Test System, and Antinuclear Antibody Test Software), By Test Type (Indirect Immunofluorescence, Enzyme-Linked Immunosorbent Assay (ELISA), and Multiplex Testing), By Disease Type (Systemic Lupus Erythematosus, Sjogren's Syndrome, Rheumatoid Arthritis, Scleroderma, and Others) By End-User (Hospitals, and Clinical Laboratories) Forecast, 2021-2027

The global ANA test market is estimated to grow considerably at a CAGR of 12.3% during the forecast period. The market is set to display impressive growth during the forecast period with some key trends, such as the high prevalence of autoimmune disorders along with rising awareness regarding this disease. According to the American Autoimmune Related Disease Association (AARDA), autoimmune disorders affect nearly 50 million people in the US, and the number is growing every year. Autoimmune disease is one of the top ten leading causes of death in women under the age of 65. According to AARDA, women account for 75% of all autoimmune disease patients. ANA testing is used in both subspecialty and primary care settings to diagnose and treat autoimmune disorders such as Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis. The use of these tests has increased after ANA was repurposed from a test for SLE to a test for any autoimmune condition.

The global ANA test market has seen strong growth during the COVID-19 crisis as the rising need for screen and test for a huge pool of patients has seen during Q1 and Q2 2020. Most major revenue-generating end-users of hospitals and clinical laboratories activities were in demand, owing to a maximum number of diagnostics examinations are performed in hospitals, and demand for ANA test increased due to the rising impact of COVID-19, also the key players will focus on the various factors such as including fulfillment of previous orders for ANA by MRO clients as well.

The global ANA market can be segmented based on product type, test type, disease type, and end-users. Based on product type, the market is classified into assay kits & reagents, antinuclear antibody test systems, and antinuclear antibody test software. Based on test type, the market is segmented into indirect immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and multiplex testing. Based on disease type, the market is segmented into systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, scleroderma, and others (Addison disease and pulmonary fibrosis). Based on end-users, the market is diversified into hospitals and clinical laboratories.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is the fastest-growing market for the ANA test. Rising government initiatives, and clinical research activities for advanced diagnosis assist the growth of the market in the region. Further, there is also a growing commitment to research, design, production, and support among healthcare manufacturers in the APAC region backed by various government initiatives.

Research Methodology

The market study of the global ANA test market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behaviour, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global ANA test Market Research and Analysis by Product Type

Global ANA test Market Research and Analysis by Test Type

Global ANA test Market Research and Analysis by Disease Type

Global ANA test Market Research and Analysis by End-user

The Report Covers

Comprehensive research methodology of the global antinuclear antibody (ANA) test market.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global antinuclear antibody (ANA) test market.

Insights about market determinants that are stimulating the global antinuclear antibody (ANA) test market.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global ANA TestIndustry
  • Recovery Scenario of Global ANA TestIndustry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global ANA Test Market by Product Type
    • 5.1.1. Assay Kits & Reagents
    • 5.1.2. Antinuclear Antibody Test System
    • 5.1.3. Antinuclear Antibody Test Software
  • 5.2. Global ANA Test Market by Test Type
    • 5.2.1. Indirect Immunofluorescence
    • 5.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 5.2.3. Multiplex Testing
  • 5.3. Global ANA Test Market by Disease Type
    • 5.3.1. Systemic Lupus Erythematosus
    • 5.3.2. Sjogren's Syndrome
    • 5.3.3. Rheumatoid Arthritis
    • 5.3.4. Scleroderma
    • 5.3.5. Others (Addison Disease And Pulmonary Fibrosis, Polymyositis, )
  • 5.4. Global ANA Test Market by End-User
    • 5.4.1. Hospitals
    • 5.4.2. Clinical Laboratories

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Abcam Plc.
  • 7.3. AESKU.GROUP GmbH
  • 7.4. American Laboratory Products Company (ALPCO)
  • 7.5. AMS S.r.l
  • 7.6. Antibodies Inc.
  • 7.7. Aviva Systems Biology Corp.
  • 7.8. BIOCOM Africa (Biotech)
  • 7.9. Bio-Rad Laboratories, Inc.
  • 7.10. ELITechGroup
  • 7.11. Erba Diagnostics Mannheim GmbH
  • 7.12. EUROIMMUN MedizinischeLabordiagnostika AG
  • 7.13. Hycor Biomedical Inc.
  • 7.14. Immuno Concepts NA Ltd.
  • 7.15. Inova Diagnostics, Inc.
  • 7.16. MBL International Corp.
  • 7.17. Merck KGaA
  • 7.18. Meridian Bioscience, Inc.
  • 7.19. Quest Diagnostics Inc.
  • 7.20. Thermo Fisher Scientific Inc.
  • 7.21. TrueHealthLabs.com.
  • 7.22. Wiener Laboratorios SAIC
  • 7.23. ZEUS Scientific, Inc.

LIST OF TABLES

  • 1. GLOBAL ANA TEST MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL ANA TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 3. GLOBALASSAY KITS & REAGENTSIN ANA TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBALANTINUCLEAR ANTIBODY TEST SYSTEMMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBALANTINUCLEAR ANTIBODY TEST SOFTWAREMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ANA TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2020-2027 ($ MILLION)
  • 7. GLOBAL INDIRECT IMMUNOFLUORESCENCE FOR ANA TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR ANA TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL MULTIPLEX TESTING FOR ANA TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL ANA TEST MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2020-2027 ($ MILLION)
  • 11. GLOBAL ANA TEST FOR SYSTEMIC LUPUS ERYTHEMATOSUS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL ANA TEST FOR SJOGREN'S SYNDROME MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL ANA TEST FOR RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL ANA TEST FOR SCLERODERMA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL ANA TEST FOR POLYMYOSITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL ANA TEST FOR AUTOIMMUNE HEPATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL ANA TEST FOR OTHERS DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL ANA TEST MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 19. GLOBAL ANA TEST IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 20. GLOBAL ANA TEST IN CLINICAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN ANA TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 22. NORTH AMERICAN ANA TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN ANA TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2020-2027 ($ MILLION)
  • 24. NORTH AMERICAN ANA TEST MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2020-2027 ($ MILLION)
  • 25. NORTH AMERICAN ANA TEST MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 26. EUROPEAN ANA TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 27. EUROPEAN ANA TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 28. EUROPEAN ANA TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2020-2027 ($ MILLION)
  • 29. EUROPEAN ANA TEST MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2020-2027 ($ MILLION)
  • 30. EUROPEAN ANA TEST MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC ANA TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 32. ASIA-PACIFIC ANA TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 33. ASIA-PACIFIC ANA TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2020-2027 ($ MILLION)
  • 34. ASIA-PACIFIC ANA TEST MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2020-2027 ($ MILLION)
  • 35. ASIA-PACIFIC ANA TEST MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 36. REST OF THE WORLD ANA TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD ANA TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 38. REST OF THE WORLD ANA TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2020-2027 ($ MILLION)
  • 39. REST OF THE WORLD ANA TEST MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2020-2027 ($ MILLION)
  • 40. REST OF THE WORLD ANA TEST MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL ANA TEST MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL ANA TEST MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL ANA TEST MARKET, 2021-2027 (%)
  • 4. GLOBAL ANA TEST MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)
  • 5. GLOBAL ANA TEST MARKET SHARE BY TEST TYPE, 2020 VS 2027 (%)
  • 6. GLOBAL ANA TEST MARKET SHARE BY DISEASE TYPE, 2020 VS 2027 (%)
  • 7. GLOBAL ANA TEST MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 8. GLOBAL ANA TEST MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL ASSAY KITS & REAGENTSIN ANA TEST MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 10. GLOBAL ANTINUCLEAR ANTIBODY TEST SYSTEMMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL ANTINUCLEAR ANTIBODY TEST SOFTWAREMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL INDIRECT IMMUNOFLUORESCENCEFOR ANA TESTMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)FOR ANA TESTMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL MULTIPLEX TESTINGFOR ANA TESTMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL ANA TEST FOR SYSTEMIC LUPUS ERYTHEMATOSUS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL ANA TEST FOR SJOGREN'S SYNDROME MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL ANA TEST FOR RHEUMATOID ARTHRITIS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL ANA TEST FOR SCLERODERMA MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 19. GLOBAL ANA TEST FOR POLYMYOSITIS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 20. GLOBAL ANA TEST FOR AUTOIMMUNE HEPATITIS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 21. GLOBAL ANA TEST FOR OTHERS DISEASE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 22. GLOBAL ANA TEST IN HOSPITALS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 23. GLOBAL ANA TEST IN CLINICAL LABORATORIESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 24. US ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. CANADA ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. UK ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. FRANCE ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. GERMANY ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. ITALY ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. SPAIN ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. REST OF EUROPE ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. INDIA ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. CHINA ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. JAPAN ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. SOUTH KOREA ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 36. REST OF THE ASIA-PACIFIC ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD ANA TEST MARKET SIZE, 2020-2027 ($ MILLION)